Overview

An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study evaluated the effect of QAB149 on dynamic and static hyperinflation, breathlessness, and health status in COPD patients
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Maleic acid